Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Sales |
1,173.81 |
999.17 |
1,036.56 |
1,086.66 |
967.39 |
Operating profit |
360.25 |
290.41 |
288.28 |
327.79 |
324.71 |
Interest |
0.80 |
0.27 |
0.19 |
27.78 |
42.83 |
Gross profit |
366.67 |
309.65 |
296.72 |
306.08 |
282.60 |
EPS (Rs) |
20.75 |
17.60 |
16.54 |
17.64 |
202.09 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Mar ' 21 |
Other income |
7.22 |
19.51 |
8.63 |
6.08 |
0.71 |
Stock adjustment |
-46.50 |
-60.58 |
12.39 |
28.94 |
-33.69 |
Raw material |
567.62 |
529.46 |
499.91 |
501.66 |
469.78 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
114.85 |
87.83 |
83.21 |
85.51 |
75.13 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
177.60 |
152.06 |
152.77 |
142.77 |
131.47 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
25.74 |
19.81 |
19.29 |
18.58 |
16.79 |
Taxation |
86.74 |
74.23 |
74.82 |
71.39 |
67.77 |
Net profit / loss |
254.19 |
215.61 |
202.61 |
216.11 |
198.05 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
24.51 |
24.51 |
24.51 |
24.51 |
1.96 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
30.69 |
29.06 |
27.81 |
30.16 |
33.57 |
GPM (%) |
31.05 |
30.40 |
28.39 |
28.01 |
29.19 |
NPM (%) |
21.52 |
21.17 |
19.39 |
19.78 |
20.46 |